$LQDA
Liquidia Corp

2024 Q1 Form 10-K Financial Statement

#000155837024003051 Filed on March 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $2.972M $4.531M $17.49M
YoY Change -33.85% -71.57% 9.75%
Cost Of Revenue $1.467M $993.0K $2.888M
YoY Change 124.31% -65.27% 1.01%
Gross Profit $1.505M $3.538M $14.60M
YoY Change -60.8% -72.94% 11.65%
Gross Profit Margin 50.64% 78.08% 83.49%
Selling, General & Admin $20.25M $17.15M $44.74M
YoY Change 159.84% -47.1% 38.05%
% of Gross Profit 1345.45% 484.6% 306.45%
Research & Development $10.06M $12.81M $43.24M
YoY Change 90.55% -34.1% 122.5%
% of Gross Profit 668.24% 361.98% 296.18%
Depreciation & Amortization $489.0K $506.0K $2.178M
YoY Change -14.06% -10.6% -40.28%
% of Gross Profit 32.49% 14.3% 14.92%
Operating Expenses $10.06M $29.97M $43.24M
YoY Change 90.55% -42.19% -16.6%
Operating Profit -$28.80M -$26.44M -$73.38M
YoY Change 211.97% -31.81% 89.28%
Interest Expense $2.524M -$1.014M $6.273M
YoY Change 124.56% -18.75% -602.64%
% of Operating Profit
Other Income/Expense, Net -$12.13M -$5.118M
YoY Change 382.57% 127.97%
Pretax Income -$40.93M -$27.45M -$78.50M
YoY Change 248.47% -33.07% 91.4%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$40.90M -$27.45M -$78.50M
YoY Change 249.57% -33.07% 91.39%
Net Earnings / Revenue -1376.18% -605.83% -448.88%
Basic Earnings Per Share -$0.54 -$1.21
Diluted Earnings Per Share -$0.54 -$0.42 -$1.21
COMMON SHARES
Basic Shares Outstanding 76.03M 64.91M 64.99M
Diluted Shares Outstanding 75.39M 64.99M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $157.9M $83.68M $83.68M
YoY Change 67.2% -10.3% -10.3%
Cash & Equivalents $157.9M $83.68M $83.68M
Short-Term Investments
Other Short-Term Assets $3.991M $2.159M $2.159M
YoY Change 247.95% 42.89% 42.89%
Inventory $3.517M
Prepaid Expenses
Receivables $2.570M $4.061M $4.061M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $167.9M $89.90M $89.90M
YoY Change 68.46% -9.93% -9.93%
LONG-TERM ASSETS
Property, Plant & Equipment $5.576M $4.480M $6.184M
YoY Change 28.3% 7.93% -1.09%
Goodwill $3.903M $3.903M
YoY Change 0.0% 0.0%
Intangibles $3.376M $3.430M
YoY Change -7.33% -7.94%
Long-Term Investments
YoY Change
Other Assets $14.73M $14.92M $14.92M
YoY Change -3.89% -3.8% -3.8%
Total Long-Term Assets $29.18M $28.43M $28.43M
YoY Change -0.18% -3.25% -3.25%
TOTAL ASSETS
Total Short-Term Assets $167.9M $89.90M $89.90M
Total Long-Term Assets $29.18M $28.43M $28.43M
Total Assets $197.1M $118.3M $118.3M
YoY Change 52.9% -8.41% -8.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.490M $1.396M $1.396M
YoY Change 196.08% -36.46% -36.46%
Accrued Expenses $15.28M $14.43M $14.43M
YoY Change 294.17% 124.73% 124.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.153M $2.722M $2.722M
YoY Change 97.57% 1403.87% 1403.87%
Total Short-Term Liabilities $21.93M $18.55M $18.55M
YoY Change 221.48% 110.8% 110.8%
LONG-TERM LIABILITIES
Long-Term Debt $80.21M $43.48M $43.48M
YoY Change 160.73% 118.73% 116.87%
Other Long-Term Liabilities $8.726M $9.007M $9.007M
YoY Change -10.01% -9.26% -9.26%
Total Long-Term Liabilities $88.93M $52.49M $52.49M
YoY Change 119.81% 164.04% 75.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.93M $18.55M $18.55M
Total Long-Term Liabilities $88.93M $52.49M $52.49M
Total Liabilities $110.9M $71.04M $71.04M
YoY Change 134.47% 83.2% 83.2%
SHAREHOLDERS EQUITY
Retained Earnings -$470.0M -$429.1M
YoY Change 29.73% 22.39%
Common Stock $76.00K $69.00K
YoY Change 16.92% 7.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $86.26M $47.29M $47.29M
YoY Change
Total Liabilities & Shareholders Equity $197.1M $118.3M $118.3M
YoY Change 52.9% -8.41% -8.41%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$40.90M -$27.45M -$78.50M
YoY Change 249.57% -33.07% 91.39%
Depreciation, Depletion And Amortization $489.0K $506.0K $2.178M
YoY Change -14.06% -10.6% -40.28%
Cash From Operating Activities -$24.87M -$15.98M -$41.56M
YoY Change 194.03% 247.21% 45.39%
INVESTING ACTIVITIES
Capital Expenditures $624.0K $206.0K $1.290M
YoY Change 70.49% -58.04% 117.91%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.000K $2.000K
YoY Change -100.0% -60.0%
Cash From Investing Activities -$624.0K -$206.0K -$11.29M
YoY Change 71.43% -58.04% 1823.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $20.00M
YoY Change 90.48%
Cash From Financing Activities 99.67M 23.64M 43.25M
YoY Change 901.7% 41377.19% -33.43%
NET CHANGE
Cash From Operating Activities -24.87M -15.98M -41.56M
Cash From Investing Activities -624.0K -206.0K -11.29M
Cash From Financing Activities 99.67M 23.64M 43.25M
Net Change In Cash 74.18M 7.454M -9.604M
YoY Change 6470.33% -247.98% -126.84%
FREE CASH FLOW
Cash From Operating Activities -$24.87M -$15.98M -$41.56M
Capital Expenditures $624.0K $206.0K $1.290M
Free Cash Flow -$25.49M -$16.19M -$42.85M
YoY Change 188.9% 217.79% 46.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001819576
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68629575
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64517912
CY2023Q4 us-gaap Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration
PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39724
CY2023 dei Entity Registrant Name
EntityRegistrantName
LIQUIDIA CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1710962
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
419 Davis Drive, Suite 100,
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Morrisville
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27560
CY2023 dei City Area Code
CityAreaCode
919
CY2023 dei Local Phone Number
LocalPhoneNumber
328-4400
CY2023 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2023 dei Trading Symbol
TradingSymbol
LQDA
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
368576944
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76027776
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Raleigh, North Carolina
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83679000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93283000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4061000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5017000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2159000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1511000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
89899000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
99811000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4480000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4151000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1704000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2101000
CY2023Q4 lqda Indemnification Asset Related Party
IndemnificationAssetRelatedParty
6707000
CY2022Q4 lqda Indemnification Asset Related Party
IndemnificationAssetRelatedParty
6595000
CY2023Q4 lqda Business Combination Contract Acquisition Costs Net
BusinessCombinationContractAcquisitionCostsNet
7922000
CY2022Q4 lqda Business Combination Contract Acquisition Costs Net
BusinessCombinationContractAcquisitionCostsNet
8604000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3430000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3726000
CY2023Q4 us-gaap Goodwill
Goodwill
3903000
CY2022Q4 us-gaap Goodwill
Goodwill
3903000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
287000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
307000
CY2023Q4 us-gaap Assets
Assets
118332000
CY2022Q4 us-gaap Assets
Assets
129198000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1396000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2197000
CY2023Q4 lqda Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
13400000
CY2022Q4 lqda Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
5522000
CY2023Q4 lqda Revenue Interest Financing Payable Current
RevenueInterestFinancingPayableCurrent
2615000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1032000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
900000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
107000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
181000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18550000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8800000
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
6707000
CY2022Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
6594000
CY2023Q4 lqda Revenue Interest Financing Payable Noncurrent
RevenueInterestFinancingPayableNoncurrent
43418000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2300000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3332000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
64000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
171000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19879000
CY2023Q4 us-gaap Liabilities
Liabilities
71039000
CY2022Q4 us-gaap Liabilities
Liabilities
38776000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68629575
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64517912
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
69000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
64000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
476322000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
440954000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429098000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-350596000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
47293000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
90422000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118332000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129198000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17488000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15935000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2888000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2859000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43242000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19435000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44742000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32411000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
90872000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
54705000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-73384000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-38770000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
3466000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1090000
CY2023 us-gaap Interest Expense
InterestExpense
6273000
CY2022 us-gaap Interest Expense
InterestExpense
2338000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2311000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-997000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5118000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2245000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41015000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64993476
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64993476
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60958862
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60958862
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
65265000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
838000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
258000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1317000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54461000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9298000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41015000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
90422000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
495000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
683000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24106000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10089000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
47293000
CY2023 us-gaap Profit Loss
ProfitLoss
-78502000
CY2022 us-gaap Profit Loss
ProfitLoss
-41015000
CY2023 lqda Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
10000000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
10089000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
9298000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2178000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3647000
CY2023 lqda Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
397000
CY2022 lqda Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
311000
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2311000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-997000
CY2023 lqda Accretion And Non Cash Interest Expense
AccretionAndNonCashInterestExpense
6093000
CY2022 lqda Accretion And Non Cash Interest Expense
AccretionAndNonCashInterestExpense
328000
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-956000
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2027000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
798000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
719000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-20000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1152000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
814000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7746000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
545000
CY2023 lqda Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-900000
CY2022 lqda Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-775000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41564000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28588000
CY2023 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
10000000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1290000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
592000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11288000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-587000
CY2023 lqda Proceeds From Revenue Interest Financing Net
ProceedsFromRevenueInterestFinancingNet
41744000
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20000000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10500000
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
2190000
CY2023 lqda Payments On Revenue Interest Financing Liability
PaymentsOnRevenueInterestFinancingLiability
1654000
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
19767000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
181000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
311000
CY2023 us-gaap Loss Contingency Receivable Proceeds
LossContingencyReceivableProceeds
113000
CY2022 us-gaap Loss Contingency Receivable Proceeds
LossContingencyReceivableProceeds
451000
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24238000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
54461000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1178000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1096000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43248000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64964000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9604000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35789000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93283000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57494000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83679000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93283000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
360000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1626000
CY2023 lqda Operating Lease Liabilities Cash Paid
OperatingLeaseLiabilitiesCashPaid
1283000
CY2022 lqda Operating Lease Liabilities Cash Paid
OperatingLeaseLiabilitiesCashPaid
1244000
CY2023 lqda Offering Costs Incurred Unpaid Included In Accrued Expenses And Accounts Payable
OfferingCostsIncurredUnpaidIncludedInAccruedExpensesAndAccountsPayable
132000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
239000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
139000
CY2023 lqda Increase In Indemnification Asset Through Accounts Payable
IncreaseInIndemnificationAssetThroughAccountsPayable
112000
CY2022 lqda Increase In Indemnification Asset Through Accounts Payable
IncreaseInIndemnificationAssetThroughAccountsPayable
313000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78500000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41000000.0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429100000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the period. These estimates are based on historical experience and various other assumptions believed to be reasonable under the circumstances. We evaluate our estimates on an ongoing basis, including those related to the valuation of stock-based awards, certain accruals, the revenue interest financing payable, and intangible and contract acquisition cost amortization, and make changes to the estimates and related disclosures as our experience develops or new information becomes known. Actual results will most likely differ from those estimates.</p>
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 lqda Inventory Capitalized Cost
InventoryCapitalizedCost
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11648571
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8601571
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19794000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18265000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15314000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14114000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4480000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4151000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1200000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1400000
CY2022 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
300000
CY2023 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
300000
CY2023Q4 lqda Contract Acquisition Costs Gross
ContractAcquisitionCostsGross
12980000
CY2023Q4 lqda Contract Acquisition Costs Accumulated Amortization
ContractAcquisitionCostsAccumulatedAmortization
5058000
CY2023Q4 lqda Contract Acquisition Costs Net
ContractAcquisitionCostsNet
7922000
CY2022Q4 lqda Contract Acquisition Costs Gross
ContractAcquisitionCostsGross
12980000
CY2022Q4 lqda Contract Acquisition Costs Accumulated Amortization
ContractAcquisitionCostsAccumulatedAmortization
4376000
CY2022Q4 lqda Contract Acquisition Costs Net
ContractAcquisitionCostsNet
8604000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5620000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2190000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3430000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5620000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1894000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3726000
CY2023 lqda Business Combination Amortization Expense
BusinessCombinationAmortizationExpense
700000
CY2022 lqda Business Combination Amortization Expense
BusinessCombinationAmortizationExpense
1500000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8544000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2862000
CY2023Q4 lqda Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2902000
CY2022Q4 lqda Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1757000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1954000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
903000
CY2023Q4 lqda Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
13400000
CY2022Q4 lqda Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
5522000
CY2023Q4 lqda Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
110000000
CY2023Q4 lqda Common Stock And Preferred Stock Par Or Stated Value Per Share
CommonStockAndPreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 lqda Share Based Compensation Arrangement By Share Based Payment Award Threshold Increase In Shares Available For Issuance As Percentage Of Stock Issued And Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardThresholdIncreaseInSharesAvailableForIssuanceAsPercentageOfStockIssuedAndOutstanding
0.010
CY2020Q4 lqda Share Based Compensation Arrangement By Share Based Payment Award Threshold Increase In Shares Available For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardThresholdIncreaseInSharesAvailableForIssuance
150000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10089000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9298000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8398262
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.49
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1463846
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.57
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
137576
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.59
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
150595
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.60
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9573937
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.80
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
69440000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5688548
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.44
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
43433000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8974357
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.75
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
65561000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.09
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
495000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
837000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
468000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
553000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
10143000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4427000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
407726
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.57
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1508166
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.50
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
201880
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
5.41
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
56034
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
6.22
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1657978
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
6.41
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
66956000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
59241000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3942000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3942000
CY2023Q4 lqda Deferred Tax Assets Research And Development Section174 Costs
DeferredTaxAssetsResearchAndDevelopmentSection174Costs
9446000
CY2022Q4 lqda Deferred Tax Assets Research And Development Section174 Costs
DeferredTaxAssetsResearchAndDevelopmentSection174Costs
4584000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1520000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4637000
CY2023Q4 lqda Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
863000
CY2022Q4 lqda Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
1157000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1982000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
621000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
404000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
369000
CY2023Q4 lqda Deferred Tax Assets Patent Amortization
DeferredTaxAssetsPatentAmortization
396000
CY2022Q4 lqda Deferred Tax Assets Patent Amortization
DeferredTaxAssetsPatentAmortization
476000
CY2023Q4 lqda Deferred Tax Assets Accrued Litigation Costs
DeferredTaxAssetsAccruedLitigationCosts
1652000
CY2022Q4 lqda Deferred Tax Assets Accrued Litigation Costs
DeferredTaxAssetsAccruedLitigationCosts
1546000
CY2023Q4 lqda Deferred Tax Assets Settlement Reserve
DeferredTaxAssetsSettlementReserve
130000
CY2022Q4 lqda Deferred Tax Assets Settlement Reserve
DeferredTaxAssetsSettlementReserve
123000
CY2023Q4 lqda Deferred Tax Assets Licensing Agreement
DeferredTaxAssetsLicensingAgreement
2367000
CY2022Q4 lqda Deferred Tax Assets Licensing Agreement
DeferredTaxAssetsLicensingAgreement
0
CY2023Q4 lqda Deferred Tax Assets Original Issue Discount Interest
DeferredTaxAssetsOriginalIssueDiscountInterest
383000
CY2022Q4 lqda Deferred Tax Assets Original Issue Discount Interest
DeferredTaxAssetsOriginalIssueDiscountInterest
0
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
21000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
87963000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74549000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2099000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2149000
CY2023Q4 lqda Deferred Tax Liabilities Adjustments Due To Changes In Accounting Methods
DeferredTaxLiabilitiesAdjustmentsDueToChangesInAccountingMethods
0
CY2022Q4 lqda Deferred Tax Liabilities Adjustments Due To Changes In Accounting Methods
DeferredTaxLiabilitiesAdjustmentsDueToChangesInAccountingMethods
21000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1652000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1546000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
447000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
582000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2099000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2149000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13400000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16486000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8613000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2553000
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.033
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1787000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.044
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
493000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
2015000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.026
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
310000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.008
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
2823000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.036
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
1159000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.029
CY2023 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
260000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.003
CY2022 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
1368000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.033
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
34000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13414000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.178
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7562000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.184
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
455000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
65000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 lqda North Carolina Corporate Income Tax Rate
NorthCarolinaCorporateIncomeTaxRate
0.025
CY2023 lqda North Carolina Corporate Income Tax Rate Expected
NorthCarolinaCorporateIncomeTaxRateExpected
0
CY2023 lqda Income Tax Expense Due To Reduction In North Carolina Deferred Tax Assets
IncomeTaxExpenseDueToReductionInNorthCarolinaDeferredTaxAssets
5700000
CY2023 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.065
CY2023 us-gaap Lease Cost
LeaseCost
891000
CY2022 us-gaap Lease Cost
LeaseCost
947000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.103
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.065
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1317000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
115000
CY2023Q4 lqda Lease Liability Payments Due Next Twelve Months
LeaseLiabilityPaymentsDueNextTwelveMonths
1432000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1356000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
64000
CY2023Q4 lqda Lease Liability Payments Due Year Two
LeaseLiabilityPaymentsDueYearTwo
1420000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1158000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0
CY2023Q4 lqda Lease Liability Payments Due Year Three
LeaseLiabilityPaymentsDueYearThree
1158000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3831000
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
179000
CY2023Q4 lqda Lease Liability Payments Due Total
LeaseLiabilityPaymentsDueTotal
4010000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
499000
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
8000
CY2023Q4 lqda Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
507000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3332000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
171000
CY2023Q4 lqda Lease Liability
LeaseLiability
3503000
CY2023Q4 lqda Revenue Interest Financing Payable Current
RevenueInterestFinancingPayableCurrent
2600000
CY2023Q1 lqda Revenue Interest Financing Agreement
RevenueInterestFinancingAgreement
32500000
lqda Revenue Interest Financing Agreement Issuance Costs
RevenueInterestFinancingAgreementIssuanceCosts
906000
lqda Revenue Interest Financing Agreement Amount Funded Under Second Tranche
RevenueInterestFinancingAgreementAmountFundedUnderSecondTranche
10000000
lqda Revenue Interest Financing Agreement Accretion
RevenueInterestFinancingAgreementAccretion
5974000
lqda Revenue Interest Financing Agreement Amortization Of Debt Discount
RevenueInterestFinancingAgreementAmortizationOfDebtDiscount
119000
lqda Payments On Revenue Interest Financing Liability
PaymentsOnRevenueInterestFinancingLiability
1654000
CY2023Q4 lqda Revenue Interest Financing Agreement
RevenueInterestFinancingAgreement
46033000
CY2023Q4 lqda Revenue Interest Financing Payable Current
RevenueInterestFinancingPayableCurrent
2615000
CY2023Q4 lqda Revenue Interest Financing Payable Noncurrent
RevenueInterestFinancingPayableNoncurrent
43418000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2300000
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
700000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000

Files In Submission

Name View Source Status
0001558370-24-003051-index-headers.html Edgar Link pending
0001558370-24-003051-index.html Edgar Link pending
0001558370-24-003051.txt Edgar Link pending
0001558370-24-003051-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lqda-20231231.xsd Edgar Link pending
lqda-20231231x10k.htm Edgar Link pending
lqda-20231231x10k001.jpg Edgar Link pending
lqda-20231231xex10d19.htm Edgar Link pending
lqda-20231231xex10d20.htm Edgar Link pending
lqda-20231231xex10d4.htm Edgar Link pending
lqda-20231231xex10d47.htm Edgar Link pending
lqda-20231231xex10d49.htm Edgar Link pending
lqda-20231231xex10d50.htm Edgar Link pending
lqda-20231231xex10d50001.jpg Edgar Link pending
lqda-20231231xex10d51.htm Edgar Link pending
lqda-20231231xex10d6.htm Edgar Link pending
lqda-20231231xex10d7.htm Edgar Link pending
lqda-20231231xex10d8.htm Edgar Link pending
lqda-20231231xex10d9.htm Edgar Link pending
lqda-20231231xex14d1.htm Edgar Link pending
lqda-20231231xex14d1001.jpg Edgar Link pending
lqda-20231231xex14d1002.jpg Edgar Link pending
lqda-20231231xex14d1008.jpg Edgar Link pending
lqda-20231231xex21d1.htm Edgar Link pending
lqda-20231231xex23d1.htm Edgar Link pending
lqda-20231231xex31d1.htm Edgar Link pending
lqda-20231231xex31d2.htm Edgar Link pending
lqda-20231231xex32d1.htm Edgar Link pending
lqda-20231231xex32d2.htm Edgar Link pending
lqda-20231231xex4d7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lqda-20231231_cal.xml Edgar Link unprocessable
lqda-20231231x10k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
lqda-20231231_lab.xml Edgar Link unprocessable
lqda-20231231_pre.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lqda-20231231_def.xml Edgar Link unprocessable